Onesource Specialty Pharma Limited Financial Ratios
ONESOURCE · Healthcare · Current price ₹1,415
P/E ratio
-364.5x
P/B ratio
3.0x
ROE
-1.3%
ROCE
0.4%
Debt / Equity
0.22
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -364.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -1.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 0.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.22 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Onesource Specialty Pharma Limited's latest numbers.
Onesource Specialty Pharma Limited profitability
Onesource Specialty Pharma Limited generates a return on equity of -1.3% and a return on capital employed of 0.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.22 and a P/E of -364.5x, Onesource Specialty Pharma Limited is conservatively financed. Our overall business-quality score for the company is 3.6 / 10.
Understand the ratios
More on Onesource Specialty Pharma Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.